共有 50 笔近期内部人交易记录记录,涉及 Aridis Pharmaceuticals, Inc. (ARDS), 包括 41 笔买入 和 8 笔卖出. 内部人买入总额为 $2.19M 内部人卖出总额为 $3.41M.
近期活跃的重要内部人包括 Hamilton John F, Windham-bannister Susan Richards, Jafri Hasan. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — ARDS
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-06-27 |
Hamilton John F |
Director |
限制性股票授予 (RSU) |
200,000 |
$0.06 |
$12.6K |
269,040 |
| 2024-06-27 |
Windham-bannister Susan Richards |
Director |
限制性股票授予 (RSU) |
200,000 |
$0.06 |
$12.6K |
261,000 |
| 2024-06-27 |
Jafri Hasan |
Chief Medical Officer |
限制性股票授予 (RSU) |
250,000 |
$0.06 |
$15.75K |
382,495 |
| 2024-06-24 |
Patzer Eric |
Director |
知情买入 |
714,286 |
$0.07 |
$50K |
884,600 |
| 2024-06-24 |
Truong Vu |
CEO |
知情买入 |
714,286 |
$0.07 |
$50K |
1,378,639 |
| 2023-09-18 |
Hamilton John F |
Director |
限制性股票授予 (RSU) |
15,000 |
$0.08 |
$1.2K |
91,540 |
| 2023-09-18 |
Windham-bannister Susan Richards |
Director |
限制性股票授予 (RSU) |
15,000 |
$0.08 |
$1.2K |
73,500 |
| 2023-09-18 |
Patzer Eric |
Executive Chairman |
限制性股票授予 (RSU) |
15,000 |
$0.08 |
$1.2K |
161,862 |
| 2023-09-18 |
Truong Vu |
CEO and Director |
限制性股票授予 (RSU) |
30,000 |
$0.08 |
$2.4K |
817,750 |
| 2023-09-18 |
Jafri Hasan |
Chief Medical Officer |
限制性股票授予 (RSU) |
20,000 |
$0.08 |
$1.6K |
175,000 |
| 2023-06-05 |
Hamilton John F |
Director |
期权行权(卖出) |
5,000 |
- |
- |
5,000 |
| 2023-06-05 |
Kurland Fred |
CFO |
期权行权(卖出) |
4,000 |
- |
- |
4,000 |
| 2023-06-05 |
Windham-bannister Susan Richards |
Director |
期权行权(卖出) |
5,000 |
- |
- |
5,000 |
| 2023-06-05 |
Patzer Eric |
Executive Chairman |
期权行权(卖出) |
12,000 |
- |
- |
12,000 |
| 2023-06-05 |
Truong Vu |
CEO and Director |
期权行权(卖出) |
15,000 |
- |
- |
15,000 |
| 2023-06-05 |
Jafri Hasan |
Chief Medical Officer |
期权行权(卖出) |
10,000 |
- |
- |
10,000 |
| 2023-05-04 |
Hamilton John F |
Director |
限制性股票授予 (RSU) |
15,000 |
$0.16 |
$2.4K |
76,540 |
| 2023-05-04 |
Kurland Fred |
CFO |
限制性股票授予 (RSU) |
10,000 |
$0.16 |
$1.6K |
84,575 |
| 2023-05-04 |
Windham-bannister Susan Richards |
Director |
限制性股票授予 (RSU) |
15,000 |
$0.16 |
$2.4K |
58,500 |
| 2023-05-04 |
Patzer Eric |
Executive Chairman |
限制性股票授予 (RSU) |
30,000 |
$0.16 |
$4.8K |
146,862 |
| 2023-05-04 |
Truong Vu |
CEO and Director |
限制性股票授予 (RSU) |
100,000 |
$0.16 |
$16K |
787,750 |
| 2023-05-04 |
Jafri Hasan |
Chief Medical Officer |
限制性股票授予 (RSU) |
25,000 |
$0.16 |
$4K |
155,000 |
| 2022-12-08 |
Cystic Fibrosis Foundation |
Director |
处置 |
- |
- |
- |
5,168,732 |
| 2022-12-05 |
Ruffolo Robert R |
Director |
限制性股票授予 (RSU) |
10,000 |
- |
- |
10,000 |
| 2022-12-05 |
Hamilton John F |
Director |
限制性股票授予 (RSU) |
10,000 |
- |
- |
10,000 |
| 2022-12-05 |
Kurland Fred |
Chief Financial Officer |
限制性股票授予 (RSU) |
8,000 |
- |
- |
8,000 |
| 2022-12-05 |
Gibbs Craig S |
Director |
限制性股票授予 (RSU) |
10,000 |
- |
- |
10,000 |
| 2022-12-05 |
Windham-bannister Susan Richards |
Director |
限制性股票授予 (RSU) |
10,000 |
- |
- |
10,000 |
| 2022-12-05 |
Patzer Eric |
Executive Chairman |
限制性股票授予 (RSU) |
24,000 |
- |
- |
24,000 |
| 2022-12-05 |
Truong Vu |
Chief Executive Officer |
限制性股票授予 (RSU) |
30,000 |
- |
- |
30,000 |
| 2022-12-05 |
Jafri Hasan |
Chief Medical Officer |
限制性股票授予 (RSU) |
20,000 |
- |
- |
20,000 |
| 2022-06-07 |
Truong Vu |
CEO and Director |
限制性股票授予 (RSU) |
88,360 |
$1.06 |
$93.66K |
687,750 |
| 2021-12-12 |
Blech Isaac |
Director |
处置 |
234,860 |
$14.50 |
$3.41M |
- |
| 2021-10-04 |
Ruffolo Robert R |
Director |
限制性股票授予 (RSU) |
7,000 |
$3.60 |
$25.2K |
49,791 |
| 2021-10-04 |
Hamilton John F |
Director |
限制性股票授予 (RSU) |
9,400 |
$3.60 |
$33.84K |
61,540 |
| 2021-10-04 |
Kurland Fred |
CFO |
限制性股票授予 (RSU) |
20,000 |
$3.60 |
$72K |
74,575 |
| 2021-10-04 |
Gibbs Craig S |
Director |
限制性股票授予 (RSU) |
7,900 |
$3.60 |
$28.44K |
60,040 |
| 2021-10-04 |
Windham-bannister Susan Richards |
Director |
限制性股票授予 (RSU) |
8,500 |
$3.60 |
$30.6K |
43,500 |
| 2021-10-04 |
Jafri Hasan |
Chief Medical Officer |
限制性股票授予 (RSU) |
30,000 |
$3.60 |
$108K |
120,000 |
| 2021-09-07 |
Jafri Hasan |
Chief Medical Officer |
知情买入 |
1,991 |
$4.15 |
$8.26K |
5,000 |
| 2021-09-03 |
Jafri Hasan |
Chief Medical Officer |
知情买入 |
3,009 |
$4.15 |
$12.49K |
3,009 |
| 2021-07-27 |
Hamilton John F |
Director |
知情买入 |
2,000 |
$4.87 |
$9.74K |
2,000 |
| 2021-07-27 |
Patzer Eric |
Director |
知情买入 |
5,175 |
$4.84 |
$25.05K |
702,132 |
| 2021-07-27 |
Truong Vu |
CEO |
知情买入 |
5,000 |
$5.11 |
$25.55K |
737,353 |
| 2021-05-12 |
Truong Vu |
CEO and Director |
限制性股票授予 (RSU) |
53,340 |
$6.25 |
$333.38K |
599,390 |
| 2021-04-01 |
Jafri Hasan |
Chief Medical Officer |
限制性股票授予 (RSU) |
10,000 |
$5.90 |
$59K |
90,000 |
| 2021-02-18 |
Nazak Michael Adrian |
Chief Financial Officer |
期权行权 |
20,000 |
$7.84 |
$156.8K |
80,000 |
| 2020-12-22 |
Patzer Eric |
10 Percent Owner, Officer: Chairman |
赠与(送出) |
16,000 |
- |
- |
696,957 |
| 2020-06-25 |
Jafri Hasan |
Chief Medical Officer |
期权行权 |
80,000 |
$6.16 |
$492.8K |
80,000 |
| 2020-06-25 |
Jafri Hasan |
Chief Medical Officer |
限制性股票授予 (RSU) |
80,000 |
$6.16 |
$492.8K |
80,000 |
■ 知情交易 — 公开市场买卖(最具参考价值)
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期